CN110272988A - Mankind's mthfr gene polymorphic detection kit - Google Patents
Mankind's mthfr gene polymorphic detection kit Download PDFInfo
- Publication number
- CN110272988A CN110272988A CN201910530992.1A CN201910530992A CN110272988A CN 110272988 A CN110272988 A CN 110272988A CN 201910530992 A CN201910530992 A CN 201910530992A CN 110272988 A CN110272988 A CN 110272988A
- Authority
- CN
- China
- Prior art keywords
- seq
- probe
- primer
- detection kit
- pcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The method of genetic polymorphism detection and its kit including specific probe and specific primer sequence are done with label probe and specific primer sequence the present invention relates to a kind of, is suitable for biotechnology and medical domain.Kit provides for while detecting the specific primer sequence and label probe of the mankind site mthfr gene C677T and A1298C loci polymorphism, wherein the kit contains Taq enzyme, specific primer, specific probe, interior mark system.Primer and kit provided by the present invention have the advantages such as high high specificity, susceptibility, quick, high throughput, safety easy to operate, result interpretation be objective for detecting the site mthfr gene C677T and A1298C loci polymorphism simultaneously.
Description
Technical field
The present invention relates to field of biotechnology, and in particular to the mankind site mthfr gene C677T and the site A1298C are polymorphic
Property detection kit and the preparation method and application thereof.
Background technique
Folic acid is a kind of water-soluble B family vitamin (Vitamin B9), it is not present in nature also inactive,
It but is the precursor of biologically active folate (folate), active form in vivo is 5-methyltetrahydrofolate, energy
A carbon-based group (methyl or formyl) is transmitted to deoxyuridylic acid, is allowed to become deoxythymidylic acid, and then synthetic DNA, is synthetic kernel
Element necessary to acid is substance necessary to cell growth and tissue repair, even more indispensable in embryo development procedure
Nutrient.Numerous studies have demonstrated that, folic acid is the indispensable nutrient of embryo growth and development in recent years, facilitates prevention mind
Through defective tube, the generation including the birth defect very serious such as spina bifida and anencephalus.The clinical function of folic acid is in addition to prevention
Outside Foetus neural tube defect, moreover it is possible to reduce pregnant woman's hypertension of pregnancy, spontaneous abortion and fetal intrauterine growth retardation, premature labor and
The disease incidence such as newborn's under-weight, harelip, heart defect.
Methylenetetrahydrofolate reductase (methylenetetrahydrofolate red μ ctase, MTHFR) is cell
The key enzyme of internal lobe acid balance and metabolism, irreversible catalysis 5- formyl tetrahydro leaf under the conditions of existing for the purine and thymidine
Acid synthesis 5-methyltetrahydrofolate, the latter participate in the synthesis and methylation of DNA.There are two types of the common mutation of mthfr gene:
677 site C/T polymorphisms and 1298 site A/C polymorphisms.Wherein, the site C677T be the MTHFR that up to the present finds the most
Common mutational site is 45.2% in the incidence of China.Studies have shown that after 677 sites sport T by C, the third of coding
Propylhomoserin is substituted by valine, causes the thermal stability of MTHFR enzyme and enzymatic activity to reduce, and then can make homocysteine (Hcy)
Metabolism is obstructed, and accumulation causes high homotype semicanal propylhomoserin mass formed by blood stasis in vivo.High homotype semicanal propylhomoserin mass formed by blood stasis and multiple miscarriage, eclampsia
Early period, placental abruption, fetal growth restriction, fetal anomaly, stillborn foetus are related, and closely related with premature labor.In addition, 1298 site A
After becoming C, glutamic acid is replaced by alanine, equally declines the enzymatic activity of MTHFR, causes Plasma Homocysteine
It increases and the reduction of folate level, the site is up to 18.6% in the frequency of China's mutation.Inhibiting dihydro using methotrexate (MTX)
When the activity of folic acid reductase, if there are the variations by patient, serious toxicity will be caused.Therefore mthfr gene is polymorphic
Property detection for the individuation rational use of medicines have important directive significance.
At present to the detection of gene mutation and gene pleiomorphism, high-resolution fusion curve analytical technology (HRM common are
Method), direct sequencing, DNA chip technology, PCR-RFLP method, Taqman sonde method etc..Due to high-resolution solubility curve method pair
Equipment requirement is more special, and in clinical expansion, there are certain difficulties;PCR-PFLP technology relies on digestion with restriction enzyme, electricity
, often there is result misjudgment phenomenon, influence its Detection accuracy in the reasons such as swimming analysis, and in addition its detection cycle is long, flux is lower,
Also it is not suitable for the quick screening of a large amount of crowds.As the DNA direct sequencing of genetic test goldstandard, due to its expense compared with
It is low, but time-consuming and sensitivity is low for operation, it is difficult to realize large-scale promotion.DNA chip technology is due to high-throughput, easy to operate fast
The advantages that fast, is widely applied in SNP detection, but the technical costs is costly, complicated, poor repeatability, sensitivity are low, unfavorable
In large-scale promotion.Quantitative fluorescent PCR-Taqman sonde method uses fluorescent quenching and double end-labellings, for SNP site
Probe high sensitivity, the accuracy of variation design specificity are strong, and you can get it in 2-3 hour as a result, it is extensive therefore to obtain
With and promote.
Summary of the invention
It is an object of the present invention to overcome the deficiencies of the prior art and provide single tube reaction while detecting mankind's mthfr gene
The kit in the site C677T and A1298C loci polymorphism provides testing result to extracting for sample nucleic acid, it is only necessary to 2
~3 hours, while also having result interpretation simple, detection flux is big, the low advantage of testing cost.It therefore can be in general molecule
Laboratory and hospital laboratory complete corresponding detection;It carries out in clinical examination using the accurate of clinical diagnosis can be greatly increased
Property, shorten the time that patient sees a doctor, it can also the reduction of medical health system cost.
A kind of method for detecting single nucleotide polymorphism based on Taqman sonde method of the invention, comprising:
(1) in same PCR amplification system, the enriching primer of two pairs of low temperature thermal oxidations is designed, it can be by PCR to wrapping respectively
It is expanded containing 677 and 1,298 two site SNPs target templates, annealing temperature is 45~55 DEG C, the enriching primer
Nucleotide sequence is as shown in SEQ ID No.14 and SEQ ID NO:15;
(2) in same PCR amplification system, 2 group-specific primers sequences are designed, using this two group-specific primers, into
The AS-PCR that row carries out locus specificity differentiation to 677 and 1,298 two SNPs loci gene types is expanded;The core of specific primer
Nucleotide sequence is as shown in SEQ ID No.1-6;
(3) in same PCR amplification system, 2 groups of SNP specific probes of design carry out specific detection purpose template, and described 2
The nucleotide sequence of group-specific probe is respectively SEQ ID NO:7 and SEQ ID NO:8, SEQ ID NO:9 and SEQ ID
NO:10, and the specific probe 5 ' it is terminal modified be respectively FAM and HEX, Cy3 and Cy5,3 ' terminal modified have NFQ-MGB;
(4) in same PCR amplification system, while mark system and UNG enzyme decontamination system in introducing, can it is more accurate,
Parting detection steadily is carried out to sample.
(5) preferably, present invention introduces interior mark system be conservative GAPDH gene, the end of internal standard probe 5 ' of design is repaired
Decorations are ROX, and 3 ' terminal modified have NFQ-MGB.
The sequence table that mankind's mthfr gene polymorphic detection kit of the present invention is related to is as follows:
SEQ ID NO:1 5’-TCTGCGGGAGCCGATTTCA-3’
SEQ ID NO:2 5’-TCTGCGGGAGTCGATTTCA-3’
SEQ ID NO:3 5’-CAAAGCGGAAGAATGTGTCA-3’
SEQ ID NO:4 5’-AGCTGACCAGTGAAGAAAGTGT-3’
SEQ ID NO:5 5’-AGCTGACCAGTGAAGCAAGTGT-3’
SEQ ID NO:6 5’-GAACCAGGGTCCCCACTCCAG-3’
SEQ ID NO:7 5’-FAM-TGCGGGAGCCGATTTCA-NFQ-MGB-3’
SEQ ID NO:8 5’-HEX-TGCGGGAGTCGATTTCA-NFQ-MGB-3’
SEQ ID NO:9 5’-Cy3-CAGTGAAGAAAGTGTCTTTGA-NFQ-MGB-3’
SEQ ID NO:10 5’-Cy5-CAGTGAAGCAAGTGTCTTTGA-NFQ-MGB-3’
SEQ ID NO:11 5’-CATCGCTCAGACACCATGG-3’
SEQ ID NO:12 5’-GCAAGGCTCGTAGACGCGGTTC-3’
SEQ ID NO:13 5’-ROX-TCGGAGTCAACGGGTGAGTT-NFQ-MGB-3’
SEQ ID NO:14 5’-CAGCCTCTCCTGACTGTCATC-3’
SEQ ID NO:15 5’-GAGCAAGTCCCCCAAGGAG-3’
The present invention is based on Taqman sonde methods, using ARMS primer specificity amplification purpose template and SNP probe specificity
Testing goal template method establishes the multiple fluorescence quantitative in two kinds of same gene different polymorphisms of same reaction tube detection
PCR detection method, while mark system and UNG enzyme decontamination system in introducing, wherein UNG (μ racil-N-glycosylase) enzyme
For uracil-N-glycosylase, its main feature is that optimum activity temperature is 50 DEG C, 95 DEG C of inactivations, action principle is optional water
Uracil glycosidic bond in solution double-strand of the fracture containing dU or single stranded DNA, the DNA chain for having missing base of formation.It is reacted in PCR
In, non-specific PCR amplification and pollution can be prevented using UNG enzyme, provided for two kinds of polymorphisms of specific detection same gene double
Guarantee again.
Detailed description of the invention
Fig. 1 is the homozygous wild sample of 677C/C 1298A/A;
Fig. 2 is 677C/C 1298A/C heterozygous mutant sample;
Fig. 3 is 677C/T 1298A/C heterozygous mutant sample;
Fig. 4 is 677C/T 1298A/A heterozygous mutant sample;
Fig. 5 is 677T/T 1298A/A homozygous mutation sample;
Fig. 6 is 677T/T 1298C/C homozygous mutation sample.
Specific embodiment
In order to which technical problems, technical solutions and advantageous effects to be solved by the present invention are more clearly understood, below with reference to
Specific embodiment, the present invention is further explained.It should be understood that these embodiments are merely to illustrate the present invention rather than limit this hair
Bright range.In addition, it should also be understood that, after reading the content taught by the present invention, those skilled in the art can make the present invention
Various changes or modification, these equivalent forms also fall within the scope of the appended claims of the present application.
Fluorescence quantitative PCR instrument: LightCycler480 (Roche Holding Ag, Basel, Switzerland), ABI7500 (U.S.'s application life
Object system house, New York, the U.S.), ABI7500FAST (Applied biosystems, New York, the U.S.), ABI7900HT
(German Qiagen company, stops up by FAST (Applied biosystems, New York, the U.S.), QiagenRotor-Gene6000
Er Duofu, Germany), Idaho LightScanner (Idaho company, the U.S., the Idaho State, the U.S.).
Archaeal dna polymerase: ABI (U.S.), TaKaRa (Japan).
The present invention is to detect 2 groups of spies of Design for polymorphism in mankind's mthfr gene 677 and 1,298 two SNPS site simultaneously
Specific primer, wherein the nucleotide sequence of the specific primer is as shown in SEQ ID No.1-6.2 groups of ARMS specific primers
In the base pairing with type to be amplified respectively of 3 ' terminal bases, at the same in its 3 ' end 2-3 introducings reciprocal one or
Two base mispairings, to enhance specificity when amplification.
Each specific primer sequence is listed below:
677C ARMS primer: 5 '-TCTGCGGGAGCCGATTTCA-3 '
677T ARMS primer: 5 '-TCTGCGGGAGTCGATTTCA-3 '
677 downstream primers: 5 '-CAAAGCGGAAGAATGTGTCA-3 '
1298A ARMS primer: 5 '-AGCTGACCAGTGAAGAAAGTGT-3 '
1298C ARMS primer: 5 '-AGCTGACCAGTGAAGCAAGTGT-3 '
1298 downstream primers: 5 '-GAACCAGGGTCCCCACTCCAG-3 '
The present invention is while detecting the polymorphism in the site mankind's mthfr gene 677 and 1,298 two SNPS and have also been devised 2 groups
Specific probe, terminal modified the 5 ' of specific probe are respectively FAM, HEX, Cy3 and Cy5, and 3 ' terminal modified have NFQ-MGB.The base
Group itself does not generate fluorescence, therefore can substantially reduce the intensity of background signal, while being also connected with MGB on the specific probe
The Tm value of the probe can be improved 10 DEG C or so, therefore same Tm value by modification group, and MGB probe can be than common
Taqman probe designs shorter, so that probe is when identification has Single nuclear polymorphism site, specificity is stronger.
Preferably, the nucleotide sequence of the 2 group-specific probe is respectively SEQ ID NO:7 and SEQ ID NO:8,
SEQ ID NO:9 and SEQ ID NO:10
Each probe sequence is listed below:
5 '-FAM-TGCGGGAGCCGATTTCA-NFQ-MGB-3 ' of 677C detection probe
5 '-HEX-TGCGGGAGTCGATTTCA-NFQ-MGB-3 ' of 677T detection probe
5 '-Cy3-CAGTGAAGAAAGTGTCTTTGA-NFQ-MGB-3 ' of 1298A detection probe
5 '-Cy5-CAGTGAAGCAAGTGTCTTTGA-NFQ-MGB-3 ' of 1298C detection probe
In one embodiment of the invention, using the reaction of the internal standard system monitoring quantitative fluorescent PCR with the presence or absence of suppression
False negative result caused by system, instrument error and human factor.Since certain ingredients in sample to be detected may contain
PCR appearance is caused partially or completely to inhibit;Amplification instrument there may be higher than allowed band hole between it is poor, cause to expand between different pipes
Efficiency variance;Artificial sample-adding mistake may also lead to the appearance of false negative result, therefore internal standard system is used in the embodiment of the present invention
System ensure that the accuracy of testing result to eliminate above-mentioned hidden danger.The interior mark system preferably comprises interior label primer, internal standard probe.
Preferably, the interior mark system includes interior label primer and internal standard probe.The interior label primer is for human gene
The conservative region design of gene GAPDH gene relatively conservative, nucleotide sequence such as SEQ ID NO:11 and SEQ in group
Shown in ID NO:12, the internal standard probe sequence is SEQ ID NO:13;The internal standard probe 5 ' is terminal modified ROX, and 3 ' ends are repaired
It is decorated with NFQ-MGB.
5 '-CATCGCTCAGACACCATGG-3 ' of internal standard forward primer F:5 '
Internal standard reverse primer R:5 '-GCAAGGCTCGTAGACGCGGTTC-3 '
Internal standard probe 5 '-ROX-TCGGAGTCAACGGGTGAGTT-NFQ-MGB-3 ' preferably, detection reagent of the invention
Box further includes positive criteria reference substance and negative controls, and positive criteria reference substance and negative controls, which is arranged, can monitor and determine in real time
Amount PCR reaction is normally carried out, and two kinds of polymorphisms of mthfr gene involved in the present invention are contained in the positive reference substance
5 kinds of plasmid mixed liquors of MTHFR 677, MTHFR 1298 and GAPDH gene;The negative controls are sterile water.
The another object of the embodiment of the present invention is to provide a kind of while detecting mankind's MTHFR and MTRR gene pleiomorphism
Method, the method the following steps are included:
(1) sample to be tested genomic DNA is obtained;
(2) specific primer, specific probe, interior mark system, enriching primer, PCR reaction buffer, Taq are utilized
Enzyme, UNG enzyme etc. carry out quantitative fluorescent PCR reaction, and single reaction pipe can detect the mthfr gene C677T of each sample simultaneously
Site and A1298C polymorphism.
Preferably, it by taking 25 μ l reaction systems as an example, is added into reaction tube each in the mixture obtained after sample to be tested
Component final concentration and content such as table 1:
Above-mentioned system is only illustrative, can proportionally expand or shrink in practical applications the volume of mixture and its
Middle each component content.
Specifically, the program of the quantitative fluorescent PCR reaction are as follows:
Step 1: 50 DEG C of 2min, 95 DEG C of 10min;
Step 2: 95 DEG C of 15s, 45 DEG C~55 DEG C 1min, 5 circulations;
Step 3: 95 DEG C of 15s, 58 DEG C~62 DEG C 1min, 40 circulations;
And the fluorescence of channel FAM, HEX, Cy3, Cy5, ROX corresponding to acquisition probe are believed at 58 DEG C~62 DEG C of the phase III
Number;
Program operation finishes, and PCR thin-walled reaction tube or the taking-up of eight unions are put into concave-convex bag, sealing is obturaged, by pollution
Source processing.
Preferably, the program of the quantitative fluorescent PCR reaction are as follows:
Step 1: 50 DEG C of 2min, 95 DEG C of 10min;
Step 2: 95 DEG C of 15s, 48 DEG C~53 DEG C 1min, 5 circulations;
Step 3: 95 DEG C of 15s, 60 DEG C~62 DEG C 1min, 40 circulations;
And the fluorescence of channel FAM, HEX, Cy3, Cy5, ROX corresponding to acquisition probe are believed at 60 DEG C~62 DEG C of the phase III
Number;
Program operation finishes, and PCR thin-walled reaction tube or the taking-up of eight unions are put into concave-convex bag, sealing is obturaged, by pollution
Source processing.
After above-mentioned PCR reaction, acquired results carry out result judgement by table 2:
The present invention is further described below by way of specific embodiment.
Embodiment 1
1, primer and probe synthesis:
Design and synthesize 2 group-specific primers SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3;SEQ ID NO:
4,SEQ ID NO:5;SEQ ID NO:6;2 group-specific probe SEQ ID NO:7, SEQ ID NO:8;SEQ ID NO:9,
SEQ ID NO:10, and flag F AM, HEX, Cy3 and Cy5 fluorophor are held 5 ', 3 ' end label NFQ-MGB, which do not shine, is quenched base
Group;2 enriching primer SEQ ID NO:14, SEQ ID NO:15.Primer, probe are prepared into 100 μM of mother liquor storage respectively.
1,1 pair of interior label primer for human genome design, the primer pair sequence mark system in preparing: are designed and synthesized
For SEQ ID NO:11 and SEQ ID NO:12;Internal standard probe is designed and synthesized, which is SEQ ID NO:13.By primer,
Probe is prepared into 100 μM of mother liquor storage respectively.
2, prepare other reagents: preparation PCR buffer, wherein the MgCl2 containing 1.0mM, dATP, dUTP, dGTP and
Each 1.0mM of dCTP;Enzyme mixation is prepared, wherein containing 0.5 × 103 μ of Taq enzyme/ml, 0.1 × 103 μ of UNG enzyme/ml.
4, positive criteria reference substance and negative controls are prepared, are contained involved in the present invention in the positive reference substance
5 kinds of plasmid mixed liquors of two kinds of polymorphism MTHFR 677 of mthfr gene, MTHFR 1298 and GAPDH gene;The feminine gender is right
It is sterile water according to product.
5, PCR reaction solution is prepared: the preparation of PCR reaction system is carried out according to the following table 3:
6, it assembles kit: including four components, PCR buffer, enzyme mixation, positive reference substance and feminine gender in kit
Reference substance calculates 12 person-portions and each ingredient usage amount of 24 person-portions, two kinds of specifications, matches according to each ingredient usage amount of PCR reaction system
It ingredient and is assembled in each pipe of kit processed.
Embodiment 2
Side sample is treated with mankind's mthfr gene polymorphic detection kit prepared by embodiment 1 to detect.
1, blood sample extracting genome DNA
With poba gene group pillar extracts kit, operating procedure, extracts human blood genome to specifications.With purple
The concentration of outer spectrophotometer detection gained sample DNA solution, is then diluted to 10ng/ μ l for sample DNA, takes 2 μ l-5 μ respectively
L is added into embodiment 1 in kit obtained and carries out the PCR reaction of next step.
2, the kit for the embodiment 1 for successively taking 2 μ l to be added separately to 23 μ l the DNA sample after diluting in step 1
In reaction system, and it is put into fluorescence quantitative PCR instrument, is carried out amplification reaction after PCR response procedures are set as described below:
50 DEG C of 2min, 95 DEG C of 10min;
95 DEG C of 15s, 48 DEG C~53 DEG C 1min, 5 circulations;
95 DEG C of 15s, 60 DEG C~62 DEG C 1min, 40 circulations;The glimmering of FAM, HEX, Cy3, Cy5, ROX is collected after each circulation
Optical signal.
The Analysis of test results of sample: the testing result of 18 samples is as follows:
677C/C 1298A/A homozygous wild 3, sample, one of testing result is as shown in Figure 1;
677C/C 1298A/C heterozygous mutant 1, sample, one of testing result is as shown in Figure 2;
677C/T 1298A/C heterozygous mutant 5, sample, one of testing result is as shown in Figure 3;
677C/T 1298A/A heterozygous mutant 4, sample, one of testing result is as shown in Figure 4;
677T/T 1298A/A homozygous mutation 3, sample, one of testing result is as shown in Figure 5;
677T/T 1298C/C homozygous mutation 1, sample, one of testing result is as shown in Figure 6.
Above-mentioned 18 sample fluorescences quantitative PCR detection result is consistent with sequencing result.The above result shows that the present invention is implemented
The detection kit that example provides is reliable for mankind's mthfr gene polymorphic detection result, reaches with direct Sequencing concordance rate
100%, and detection method high sensitivity is in traditional sequencing methods, it is easy to operate quickly, be conducive to large-scale promotion.
Sequence table
<110>create in the honest day in Jiangsu object Engineering Co., Ltd
<120>mankind's mthfr gene polymorphic detection kit
<160> 15
<170> SIPOSequenceListing 1.0
<210> 1
<211> 19
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 1
tctgcgggag ccgatttca 19
<210> 2
<211> 19
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 2
tctgcgggag tcgatttca 19
<210> 3
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
caaagcggaa gaatgtgtca 20
<210> 4
<211> 22
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
agctgaccag tgaagaaagt gt 22
<210> 5
<211> 22
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 5
agctgaccag tgaagcaagt gt 22
<210> 6
<211> 21
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 6
gaaccagggt ccccactcca g 21
<210> 7
<211> 17
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 7
tgcgggagcc gatttca 17
<210> 8
<211> 17
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 8
tgcgggagtc gatttca 17
<210> 9
<211> 21
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 9
cagtgaagaa agtgtctttg a 21
<210> 10
<211> 21
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 10
cagtgaagca agtgtctttg a 21
<210> 11
<211> 19
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 11
catcgctcag acaccatgg 19
<210> 12
<211> 22
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 12
gcaaggctcg tagacgcggt tc 22
<210> 13
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 13
tcggagtcaa cgggtgagtt 20
<210> 14
<211> 21
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 14
cagcctctcc tgactgtcat c 21
<210> 15
<211> 19
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 15
gagcaagtcc cccaaggag 19
Claims (10)
1. being used for while detecting the kit in the mankind site mthfr gene C677T and A1298C loci polymorphism, it is characterised in that
It is located in box body equipped with box body, liner, PCR mixing liquid pipe, enzyme mixation pipe, positive control pipe and negative control pipe, liner,
PCR mixing liquid pipe, enzyme mixation pipe, positive control pipe and negative control pipe are inserted into respectively in the hole of liner;PCR is mixed in liquid pipe
Equipped with PCR mixed liquor, enzyme mixation pipe is provided with enzyme mixation, and positive control pipe is provided with positive criteria reference substance, negative right
It looks after and is provided with negative standards' reference substance.
2. detection kit according to claim 1, which is characterized in that reacted in the detection kit comprising 1 × PCR
Liquid, 3.0mM MgCl2, dATP, dCTP, dGTP, dUTP, dTTP each 0.2mM, each 0.2 μM of probe, each 0.4 μM of primer;Institute
Stating enzyme mixation includes 5 μ/μ L Taq archaeal dna polymerase, 0.1 μ/μ L μ NG enzyme.
3. detection kit according to claim 1, which is characterized in that contain 2 group-specifics in the detection kit
Primer sequence, the nucleotide sequence of the specific primer is as shown in SEQ ID No.1-6.
4. detection kit according to claim 1, which is characterized in that also special containing 2 groups in the detection kit
Property probe, the nucleotide sequence of the 2 group-specific probe are respectively SEQ ID NO:7 and SEQ ID NO:8, SEQ ID NO:
9 with SEQ ID NO:10, and the specific probe 5 ' it is terminal modified be respectively FAM and HEX, Cy3 and Cy5,3 ' terminal modified have
NFQ-MGB。
5. detection kit according to claim 1, which is characterized in that the detection kit further includes interior mark system,
The interior mark system includes interior label primer and internal standard probe, the nucleotide sequence of the primer such as SEQ ID NO:11 and SEQ ID
Shown in NO:12, the nucleotide sequence of the internal standard probe is as shown in SEQ ID NO:13.
6. detection kit according to claim 3, which is characterized in that the terminal modified internal standard probe 5 ' is ROX, 3 ' ends
It is modified with NFQ-MGB.
7. detection kit according to claim 3, which is characterized in that the detection kit further includes two low annealing
The enriching primer of temperature is respectively used to the template in the enrichment site C677T and the site A1298C, the nucleotides sequence of the enriching primer
Column are as shown in SEQ ID No.14 and SEQ ID NO:15.
8. kit according to any one of claims 1-7 detects the site mthfr gene C677T and A1298C simultaneously
The method of loci polymorphism, which comprises the following steps:
(1) sample to be tested genomic DNA is obtained;
(2) using the specific primer, specific probe, interior mark system, enriching primer, PCR reaction buffer, Taq enzyme,
UNG enzyme etc. carry out quantitative fluorescent PCR reaction, single tube reaction can detect simultaneously each sample the site mthfr gene C677T and
A1298C polymorphism.
9. according to the method described in claim 8, it is characterized in that, the system of quantitative fluorescent PCR reaction are as follows:
10. method according to claim 8 or claim 9, which is characterized in that the fluorescent quantitative PCR program are as follows:
Step 1: 50 DEG C of 2min, 95 DEG C of 10min;
Step 2: 95 DEG C of 15s, 45 DEG C~55 DEG C 1min, 5 circulations;
Step 3: 95 DEG C of 15s, 58 DEG C~62 DEG C 1min, 40 circulations;
And at 58 DEG C~62 DEG C of the phase III channel FAM, HEX, Cy3, Cy5, ROX corresponding to acquisition probe fluorescence signal;
Program operation finishes, and PCR thin-walled reaction tube or the taking-up of eight unions are put into concave-convex bag, sealing is obturaged, at pollution sources
Reason.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910530992.1A CN110272988A (en) | 2019-06-19 | 2019-06-19 | Mankind's mthfr gene polymorphic detection kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910530992.1A CN110272988A (en) | 2019-06-19 | 2019-06-19 | Mankind's mthfr gene polymorphic detection kit |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110272988A true CN110272988A (en) | 2019-09-24 |
Family
ID=67961378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910530992.1A Pending CN110272988A (en) | 2019-06-19 | 2019-06-19 | Mankind's mthfr gene polymorphic detection kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110272988A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112662751A (en) * | 2020-12-24 | 2021-04-16 | 中生北控生物科技股份有限公司 | Primer combination, kit and detection method for detecting MTHFR gene polymorphism |
WO2021128659A1 (en) * | 2019-12-24 | 2021-07-01 | 陕西佰美基因股份有限公司 | Specific primer probe combination and applicatoin thereof suitable for test of folate metabolic capability gene by direct blood amplification combined with fluorescent pcr method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110004215A (en) * | 2018-01-04 | 2019-07-12 | 江苏正大天创生物工程有限公司 | Mankind's mthfr gene polymorphic detection kit |
-
2019
- 2019-06-19 CN CN201910530992.1A patent/CN110272988A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110004215A (en) * | 2018-01-04 | 2019-07-12 | 江苏正大天创生物工程有限公司 | Mankind's mthfr gene polymorphic detection kit |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021128659A1 (en) * | 2019-12-24 | 2021-07-01 | 陕西佰美基因股份有限公司 | Specific primer probe combination and applicatoin thereof suitable for test of folate metabolic capability gene by direct blood amplification combined with fluorescent pcr method |
CN112662751A (en) * | 2020-12-24 | 2021-04-16 | 中生北控生物科技股份有限公司 | Primer combination, kit and detection method for detecting MTHFR gene polymorphism |
CN112662751B (en) * | 2020-12-24 | 2022-08-16 | 中生北控生物科技股份有限公司 | Primer combination, kit and detection method for detecting MTHFR gene polymorphism |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230340624A1 (en) | Detection reagents for severe acute respiratory syndrome coronavirus 2 and detection methods | |
CN106591473B (en) | A kind of people MTHFR and MTRR genetic polymorphism detections primer, probe, kit and method | |
CN103757106B (en) | Based on people's mthfr gene polymorphic detection test kit and the method for Taqman-MGB probe | |
CN106702019A (en) | Detection probe for SNP (Single Nucleotide Polymorphism) of human CYP2C19 gene and application of detection probe | |
CN105002275A (en) | Specific sequence specific primers-polymerase chain reaction primers and kit for human MTHFR and MTRR gene polymorphism detection | |
CN109182501B (en) | Folate metabolism gene polymorphism detection primer and kit | |
CN102925562B (en) | Kit and method for detecting aminoglycoside drug-induced deafness-sensitive gene | |
CN106929591A (en) | A kind of human HLA B*5801 genetic polymorphism detection kits | |
CN109182537A (en) | A kind of amplimer, kit and detection method for evaluating folic acid metabolism ability | |
CN109593846A (en) | Detect primer, probe and the kit of folic acid metabolism ability related gene | |
CN110272988A (en) | Mankind's mthfr gene polymorphic detection kit | |
CN110004215A (en) | Mankind's mthfr gene polymorphic detection kit | |
CN109321651A (en) | A kind of composition, kit, sample treatment and application detecting people CYP2D6 gene pleiomorphism | |
CN108949929A (en) | For detecting the product and its methods and applications of MTHFR and MTRR gene pleiomorphism simultaneously | |
CN111172273B (en) | Primer group, kit and detection method for SMN1 gene detection | |
CN117230195A (en) | Composition and kit for detecting BCR-ABL1P210 fusion gene | |
CN110317865A (en) | Mankind's MTHFR and MTRR genetic polymorphism detection kit | |
CN108913774B (en) | C-KIT somatic mutation gene detection KIT and detection method thereof | |
CN111778321A (en) | Primer and probe for detecting folate metabolism related gene, kit and application | |
CN109371113A (en) | A kind of composition, kit, sample treatment and application detecting mankind's APOE and SLCO1B1 gene pleiomorphism | |
CN107058541A (en) | PKU related gene copy number mutation test kit | |
CN108660193A (en) | Mankind's LMNA-NTRK1 Gene Fusion abrupt climatic changes primer, probe and detection kit | |
CN107034300A (en) | Carry out the genotyping detection method of MTRR Gene A 66G pleomorphism sites | |
CN110029171B (en) | A kind of kit using stem ring primer detection PIK3CA gene mutation site | |
CN112779322A (en) | Gene mutation detection kit based on non-fluorescence labeled probe and high-resolution melting curve, detection method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190924 |
|
RJ01 | Rejection of invention patent application after publication |